Ocean Biomedical Stock Buy Hold or Sell Recommendation
| OCEA Stock | 0.72 0.01 1.41% |
Given the investment horizon of 90 days and your bold attitude towards risk, our recommendation regarding Ocean Biomedical is 'Strong Sell'. Macroaxis provides Ocean Biomedical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding OCEA positions.
Check out Ocean Biomedical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide. In addition, we conduct extensive research on individual companies such as Ocean and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Ocean Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Ocean |
Execute Ocean Biomedical Buy or Sell Advice
The Ocean recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ocean Biomedical. Macroaxis does not own or have any residual interests in Ocean Biomedical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ocean Biomedical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Sell | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Ocean Biomedical Trading Alerts and Improvement Suggestions
| Ocean Biomedical generated a negative expected return over the last 90 days | |
| Ocean Biomedical has high historical volatility and very poor performance | |
| Ocean Biomedical has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (958.43 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ocean Biomedical generates negative cash flow from operations | |
| Ocean Biomedical has a poor financial position based on the latest SEC disclosures | |
| About 72.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from seekingalpha.com: Ocean Biomedical receives notice from Nasdaq regarding late filing |
Ocean Biomedical current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ocean analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ocean analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Ocean Biomedical Returns Distribution Density
The distribution of Ocean Biomedical's historical returns is an attempt to chart the uncertainty of Ocean Biomedical's future price movements. The chart of the probability distribution of Ocean Biomedical daily returns describes the distribution of returns around its average expected value. We use Ocean Biomedical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ocean Biomedical returns is essential to provide solid investment advice for Ocean Biomedical.
| Mean Return | -0.5 | Value At Risk | -6.93 | Potential Upside | 7.46 | Standard Deviation | 5.14 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ocean Biomedical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Ocean Biomedical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ocean Biomedical or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ocean Biomedical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ocean stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.56 | |
β | Beta against Dow Jones | 0.37 | |
σ | Overall volatility | 5.14 | |
Ir | Information ratio | -0.12 |
Ocean Biomedical Volatility Alert
Ocean Biomedical exhibits very low volatility with skewness of 1.88 and kurtosis of 5.65. Ocean Biomedical is a potential penny stock. Although Ocean Biomedical may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Ocean Biomedical. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Ocean instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Ocean Biomedical Fundamentals Vs Peers
Comparing Ocean Biomedical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ocean Biomedical's direct or indirect competition across all of the common fundamentals between Ocean Biomedical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ocean Biomedical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Ocean Biomedical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Ocean Biomedical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Ocean Biomedical to competition |
| Fundamentals | Ocean Biomedical | Peer Average |
| Return On Asset | -6.82 | -0.14 |
| Current Valuation | 36.97 M | 16.62 B |
| Shares Outstanding | 34.65 M | 571.82 M |
| Shares Owned By Insiders | 71.98 % | 10.09 % |
| Shares Owned By Institutions | 11.62 % | 39.21 % |
| Number Of Shares Shorted | 165.46 K | 4.71 M |
| Price To Book | 100.67 X | 9.51 X |
| EBITDA | (957.74 K) | 3.9 B |
| Net Income | (958.43 K) | 570.98 M |
| Total Debt | 2.15 M | 5.32 B |
| Book Value Per Share | (2.21) X | 1.93 K |
| Cash Flow From Operations | (747.3 K) | 971.22 M |
| Short Ratio | 2.64 X | 4.00 X |
| Earnings Per Share | (3.00) X | 3.12 X |
| Target Price | 18.5 | |
| Beta | 1.53 | -0.15 |
| Market Capitalization | 25.64 M | 19.03 B |
| Total Asset | 110.91 M | 29.47 B |
| Retained Earnings | (2.77 M) | 9.33 B |
| Working Capital | (3 M) | 1.48 B |
| Net Asset | 110.91 M |
Note: Acquisition or disposition of Ocean Biomedical securities by Ajjarapu Surendra K [view details]
Ocean Biomedical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ocean . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Ocean Biomedical Buy or Sell Advice
When is the right time to buy or sell Ocean Biomedical? Buying financial instruments such as Ocean Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ocean Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Rentals Thematic Idea Now
Rentals
Companies providing rental and leasing services to public and business. The Rentals theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rentals Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Ocean Biomedical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.00) | Return On Assets (6.82) |
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.